Overview

A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood

Status:
COMPLETED

Trial end date:
2025-01-07

Target enrollment:

Participant gender:

Summary

This trial aims to test how two different formulations of BI 690517 are taken up by the body and how probenecid influences the amount of BI 690517 in the blood.

Phase:

PHASE1

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Probenecid